Only 23 percent of the surgeons say they mix IOLs to give patients a greater depth of focus.ĭr. The J&J lenses give great contrast, amazing acuity and a fantastic range. “I have to target appropriate refractive error, usually +0.25 D sphere. ![]() Oklahoma City ophthalmologist Deena Sylvester says, “I like that the Vivity doesn’t have halos/glare, but I wish it could provide better 14- to 16-inch reading.”Ĭolorado Springs surgeon Steve Dewey likes using the J&J Tecnis MF Toric II and the new Synergy. ![]() “I get issues with late decentration day one postop and one week postop, the IOL will be perfectly centered around the pupil, but at a month I’ve noticed the IOL will shift 0.5 mm (usually inferotemporal or superotemporal), despite following most of the pearls for IOL centration.” New York’s James Hu, MD, a Vivity user, likes the lens, but sees some room for improvement. Fifteen percent implant the original Symfony EDOF Toric II lens (average number implanted per month: 3 average charge/eye: $2,324).Ī Los Angeles surgeon says, “Vivity is my favorite premium IOL because it gives an improved range of focus, largely without night driving glare problems.” Twenty-six percent of the surgeons on the survey implant the Tecnis Synergy (average number implanted per month: 9 average charge/eye: $2,656), and 22 percent implant the Tecnis Synergy Toric II (average number implanted per month: 6 average charge/eye: $2,599). Thirty-three percent of surgeons say they implant the non-toric Vivity (average number implanted per month: 7 average charge/eye: $2,524), and 24 percent implant the toric version (average number implanted per month: 6 average charge/eye: $2,911). The Synergy has been described as a kind of mix between the Symfony and the Tecnis multifocal, since it combines elements of an EDOF lens with a diffractive multifocal to provide a range of vision. The Vivity is a non-diffractive, extended-depth-of-focus IOL with a unique central optic zone. The next most popular group of premium lenses are the most recently approved ones, the Alcon Vivity and J&J Vision Tecnis Synergy lens families. “ less dysphotopsia, more near vision, and is less dependent on ocular surface,” says a surgeon from Cincinnati. Following the non-toric PanOptix was its toric counterpart, used by 46 percent of the physicians (average number implanted per month: 7 average charge/eye: $2,783).Ī New York surgeon says he uses the PanOptix due to “less haloes and a crisper quality of vision.” Another New York surgeon says he chooses the PanOptix because of “Excellent distance and near, with tolerable night distractions.” The most popular premium lens option among the respondents (with some surgeons choosing more than one option) is the PanOptix Trifocal (non-toric), with 54 percent of the respondents saying they implant it (average number implanted per month: 8 average charge/eye: $2,705). ![]() Surgeons who implant premium intraocular lenses are embracing technology such as trifocal IOLs, but are also warming up to the latest additions to the market. To read about your colleagues’ impressions of the newcomers on the IOL scene, as well as other lens technologies, read on. This time around, 22 percent of the 11,518 recipients on Review’s e-mail list opened the message, and 54 surgeons took the survey. This is just one of the findings from this year’s e-mail survey on IOL preferences. ![]() This seems to be the case with the most recent additions to the premium IOL market, the Vivity (Alcon) and the Synergy (Johnson & Johnson Vision), though a fair number of respondents on this year’s IOL survey have begun using them in patients already. Physicians often take a watchful-waiting approach, ensuring that a new lens has the efficacy and safety profile they want before incorporating it into their everyday practice. It ’s always interesting to see how new intraocular lens technology fares as it tries to capture the interest of cataract surgeons.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |